We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SEPN

Price
27.97
Stock movement down
-0.54 (-1.89%)
Company name
Septerna, Inc. Common Stock
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.25B
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
28.36%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-11-25

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

SEPN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

FINANCIALS

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-2.07

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash189.31M
Net receivables2.57M
Total current assets334.14M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment30.97M
Total assets415.23M
Accounts payable6.54M
Short/Current long term debt24.57M
Total current liabilities15.13M
Total liabilities37.67M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open28.70
Daily high28.70
Daily low26.80
Daily Volume361K
All-time high28.51
1y analyst estimate24.25
Beta-
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
SEPNS&P500
Current price drop from All-time high-1.89%-1.80%
Highest price drop-80.95%-19.00%
Date of highest drop8 Apr 20258 Apr 2025
Avg drop from high-43.59%-2.73%
Avg time to new high25 days6 days
Max time to new high227 days89 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
SEPN (Septerna, Inc. Common Stock) company logo
Marketcap
1.25B
Marketcap category
Small-cap
Description
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Employees
75
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...